paxilline has been researched along with dihydrotestosterone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Defranco, DB; Hammes, SR; O'Malley, K; Raj, GV; Sen, A; Wang, Z | 1 |
| De Castro, I; Defranco, DB; Deng, FM; Hammes, SR; Kapur, P; Melamed, J; Raj, GV; Rossi, R; Sen, A | 1 |
2 other study(ies) available for paxilline and dihydrotestosterone
| Article | Year |
|---|---|
Paxillin regulates androgen- and epidermal growth factor-induced MAPK signaling and cell proliferation in prostate cancer cells.
Topics: Androgens; Cell Line, Tumor; Cell Proliferation; Dihydrotestosterone; Epidermal Growth Factor; ErbB Receptors; Gene Expression Regulation, Neoplastic; Humans; Male; MAP Kinase Signaling System; Paxillin; Phosphorylation; Prostate-Specific Antigen; Prostatic Neoplasms; Receptors, Androgen; RNA, Messenger; RNA, Neoplasm; Transcription, Genetic | 2010 |
Paxillin mediates extranuclear and intranuclear signaling in prostate cancer proliferation.
Topics: Active Transport, Cell Nucleus; Animals; Cell Line, Tumor; Cell Nucleus; Cell Proliferation; Dihydrotestosterone; ets-Domain Protein Elk-1; Extracellular Signal-Regulated MAP Kinases; Female; Gene Expression Regulation; Granulosa Cells; Homeodomain Proteins; Humans; Male; MAP Kinase Signaling System; Mice; Mice, Inbred C57BL; Mice, Nude; Neoplasm Transplantation; Paxillin; Phosphoproteins; Promoter Regions, Genetic; Prostate-Specific Antigen; Prostatic Neoplasms; Protein Binding; Proto-Oncogene Proteins c-fos; Receptors, Androgen; Transcription Factors; Transcription, Genetic; Transcriptional Activation | 2012 |